✦ LIBER ✦

Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

✍ Scribed by M. Gnant

Book ID: 106323341
Publisher: Blackwell Publishing
Year: 2003
Tongue: German
Weight: 51 KB
Volume: 35
Category: Article
ISSN: 0001-544X
DOI: 10.1007/s10353-003-0045-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase-II Trial Using Gemcitabine as Mono

Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

✍ F. Meyer; K. Eichelmann; H. Lippert; K. Ridwelski 📂 Article 📅 2003 🏛 Blackwell Publishing 🌐 German ⚖ 97 KB

Phase II trial using gemcitabine as mono

Phase II trial using gemcitabine as monochemotherapy in patients with metastasized pancreatic cancer

✍ F. Kober; K. Glaser 📂 Article 📅 2004 🏛 Blackwell Publishing 🌐 German ⚖ 38 KB

A phase I/II multicentric trial of gemci

A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma

✍ Eickhoff, A; Martin, W; Hartmann, D; Eickhoff, J C; Möhler, M; Galle, P R; Riema 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

Phase II trial of gemcitabine and UFT mo

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma

✍ J. Feliu; M. P. López Álvarez; M. A. Jaraiz; M. Constenla; J. M. Vicent; J. Beló 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

Phase II trial of high-dose gemcitabine

Phase II trial of high-dose gemcitabine in patients with metastatic pancreatic adenocarcinoma

✍ W. Scheithauer; G. Kornek; H. Ulrich-Pur; M. Raderer; W. Fiebiger; G. Zickero; J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 157 KB